Bacterial cell wall and membrane synthesis machinery

The bacterial cell wall and membrane synthesis machinery is a coordinated system of enzymes and structural components essential for the biogenesis and maintenance of the bacterial cell envelope [1.2.1, 1.2.3]. This machinery is responsible for the synthesis of peptidoglycan, a rigid polymer that provides osmotic protection and determines cell shape [1.1.2, 1.2.5]. The biosynthetic pathway spans the cytoplasm, where Mur enzymes produce precursors; the cytoplasmic membrane, where MraY and MurG assemble Lipid II; and the periplasm or extracellular space, where Penicillin-Binding Proteins (PBPs) catalyze the final cross-linking of the cell wall [1.1.1, 1.2.1]. Because many of these components are unique to bacteria and absent in humans, they are prime targets for selective antimicrobial therapy [1.2.1, 1.4.2]. Antibiotics such as beta-lactams and glycopeptides inhibit the assembly of the peptidoglycan layer, while membrane-active agents like daptomycin and polymyxins disrupt the integrity of the lipid bilayer or the outer membrane [1.3.1, 1.3.2]. Targeting this machinery is a cornerstone of treating bacterial infections, though its efficacy is increasingly challenged by the emergence of diverse resistance mechanisms [1.1.3, 1.2.2].

Other names

Bacterial cell envelope synthesis machineryPeptidoglycan biosynthesis pathwayBacterial cell wall machineryBacterial cell wall synthesis machinery

Inhibition of peptidoglycan cross-linking (transpeptidation) by binding to penicillin-binding proteins (PBPs); inhibition of peptidoglycan precursor synthesis (e.g., MurA inhibition); sequestration of Lipid II to prevent polymerization; and disruption of the bacterial cytoplasmic or outer membrane integrity and potential.